Beyond the 19,500 Genes: Unveiling the Human Dark Proteome cover art

Beyond the 19,500 Genes: Unveiling the Human Dark Proteome

Beyond the 19,500 Genes: Unveiling the Human Dark Proteome

Listen for free

View show details
In this episode, we dive deep into a groundbreaking discovery that is rewriting the textbooks on human genetics: the Human Dark Proteome. For years, it was believed the human genome encoded roughly 19,500 canonical protein-coding genes. However, new research from the international TransCODE Consortium reveals a hidden landscape of thousands of non-canonical open reading frames (ncORFs) that produce small microproteins and a newly defined class of molecules called peptideins.What You’ll Learn in This Episode:The Missing Pieces: How scientists analyzed over 95,000 proteomics experiments to find evidence for peptides in 25% of identified ncORFs.Defining "Peptideins": Explore this new classification for microproteins that have confirmed synthesis but indeterminate biological function—and why they are the next big target for drug development.The OLMALINC Breakthrough: A look at how one specific peptidein from a "non-coding" RNA is actually essential for cell mitosis and DNA damage regulation.Future Career Impact: How these discoveries are creating ripple effects across biotechnology, especially in cancer immunotherapy and genetic disease research.This episode highlights the collaborative efforts of global institutions to standardize the "dark proteome," providing a roadmap for future biomedical discovery.00:00 – 01:30 | Introduction & The "Dark Proteome"Hosts introduce the concept of the human genome beyond the 19,500 canonical genes.Explanation of the "dark proteome": the thousands of unannotated non-canonical open reading frames (ncORFs) discovered through ribosome sequencing.01:30 – 04:00 | The TransCODE ConsortiumOverview of the international collaboration between GENCODE, PeptideAtlas, and HUPO-HPP to standardize the study of these hidden molecules.The goal: bringing formal reference gene annotation status to less-well-characterized microproteins.04:00 – 06:30 | The Scale of the DiscoveryDiscussion of the massive data analysis involving 95,520 proteomics experiments.How scientists found that 25% of 7,264 ncORFs gave rise to detectable peptides.06:30 – 09:00 | Defining "Peptideins"Introducing the new classification: Peptideins.Explaining the distinction between a "canonical protein" and a peptidein (confirmed synthesis but indeterminate biological function).09:00 – 12:00 | Immunopeptidomics & Cancer ResearchDeep dive into HLA-I immunopeptidomics and why ncORF-encoded microproteins are mostly sourced from intracellular translation products.The implications for targeting cryptic antigens in cancer immunotherapy.12:00 – 14:30 | Measuring Evolutionary "ORFness"Introduction of the ORBL (ORF relative branch length) tool.How ORBL quantifies evolutionary constraint based on start/stop codon conservation even when amino acid sequences lack conventional signatures.14:30 – 17:30 | Case Study: OLMALINC & c10riboseqorf92Analysis of the OLMALINC long non-coding RNA and its essential peptidein.How this specific molecule regulates mitosis and DNA damage response, proving these "non-coding" regions have vital functional roles.17:30 – 19:15 | The Research Agenda for 2026 and BeyondOutlining the seven key challenges for the research community, including standardizing deep learning approaches and validating cancer-specific products.19:15 – 20:00 | Conclusion & Closing RemarksSummary of how this collaborative work redefines the human proteomeSource: https://www.nature.com/articles/s4158...#DarkProteome #BiologyCareerInsights #Biotechnology #Genetics #Peptideins #Microproteins #HumanGenome #LifeSciences #CancerResearch #BioTechBreakthroughs
adbl_web_anon_alc_button_suppression_c
No reviews yet